Egle Therapeutics Revenue and Competitors

Location

$46M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Egle Therapeutics's estimated annual revenue is currently $8.4M per year.(i)
  • Egle Therapeutics's estimated revenue per employee is $155,000
  • Egle Therapeutics's total funding is $46M.

Employee Data

  • Egle Therapeutics has 54 Employees.(i)
  • Egle Therapeutics grew their employee count by 13% last year.

Egle Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Egle Therapeutics?

Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.

keywords:N/A

$46M

Total Funding

54

Number of Employees

$8.4M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M540%N/A
#2
$7.6M54-2%N/A
#3
$13.1M54-17%N/A
#4
$12M540%N/A
#5
$12.2M5415%N/A